MRCP
Maple Rock Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,208,741
| Closed | -$92.8M | – | 44 |
|
|
2024
Q4 | $92.8M | Sell |
4,208,741
-350,660
| -8% | -$7.73M | 2.78% | 2 |
|
|
2024
Q3 | $82.2M | Buy |
4,559,401
+47,000
| +1% | +$847K | 2.33% | 7 |
|
|
2024
Q2 | $73.3M | Buy |
4,512,401
+149,000
| +3% | +$2.42M | 2.49% | 6 |
|
|
2024
Q1 | $61.6M | Buy |
4,363,401
+1,770,000
| +68% | +$25M | 3.41% | 8 |
|
|
2023
Q4 | $27.1M | Buy |
+2,593,401
| New | +$27.1M | 1.54% | 18 |
|